Analysis of the new coronavirus (SARS-CoV-2) based on epigenetics
- Funded by RIKEN
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Start & end year
N/AFunder
RIKENResearch Location
JapanLead Research Institution
N/AResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnosticsResearch Subcategory
Pathogen morphology, shedding & natural historySpecial Interest Tags
N/AStudy Type
Non-ClinicalClinical Trial Details
N/ABroad Policy Alignment
PendingAge Group
Not ApplicableVulnerable Population
Not applicableOccupations of Interest
Not applicable
Abstract
We are analyzing the effects of methyltransferases that cause RNA methylation such as N6-methyladenosine of SARS-CoV-2 RNA on virus replication and host response by machine learning, and exploring the possibilities to use it as a target for COVID-19 therapy.